Edaravone

Edaravone is a medication primarily used to treat amyotrophic lateral sclerosis (ALS), a progressive disease affecting nerve cells in the brain and spinal cord. It works by reducing oxidative stress, which can damage cells and contribute to the progression of ALS. By protecting nerve cells from this damage, Edaravone aims to slow down the decline in physical function in patients with the disease. It is typically administered via intravenous infusion and can be part of a broader treatment plan for managing ALS symptoms and improving quality of life.